122 related articles for article (PubMed ID: 19192887)
1. [Comparison of characteristics between glutaraldehyde- and genipin-crosslinked gelatin microspheres].
Li M; Liu X; Liu X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Jan; 23(1):87-91. PubMed ID: 19192887
[TBL] [Abstract][Full Text] [Related]
2. Genipin-crosslinked gelatin microspheres as a drug carrier for intramuscular administration: in vitro and in vivo studies.
Liang HC; Chang WH; Lin KJ; Sung HW
J Biomed Mater Res A; 2003 May; 65(2):271-82. PubMed ID: 12734822
[TBL] [Abstract][Full Text] [Related]
3. Gelatin microspheres crosslinked with genipin for local delivery of growth factors.
Solorio L; Zwolinski C; Lund AW; Farrell MJ; Stegemann JP
J Tissue Eng Regen Med; 2010 Oct; 4(7):514-23. PubMed ID: 20872738
[TBL] [Abstract][Full Text] [Related]
4. [Study on the temporal change of properties of genipin crosslinked gelatin].
Jin X; Yan J; Zhou L; Ji Y; Yang X; Xu G
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Feb; 25(1):150-3. PubMed ID: 18435279
[TBL] [Abstract][Full Text] [Related]
5. Genipin-crosslinked gelatin microspheres as a strategy to prevent postsurgical peritoneal adhesions: In vitro and in vivo characterization.
De Clercq K; Schelfhout C; Bracke M; De Wever O; Van Bockstal M; Ceelen W; Remon JP; Vervaet C
Biomaterials; 2016 Jul; 96():33-46. PubMed ID: 27135715
[TBL] [Abstract][Full Text] [Related]
6. [Preparation and ectopic osteoinduction study of macroporous bone substitute with calcium phosphate cements and rhBMP-2 loaded gelatin microspheres].
Li M; Liu XD; Liu XY; Ge BF
Zhongguo Gu Shang; 2011 May; 24(5):411-5. PubMed ID: 21688541
[TBL] [Abstract][Full Text] [Related]
7. A genipin-crosslinked gelatin membrane as wound-dressing material: in vitro and in vivo studies.
Chang WH; Chang Y; Lai PH; Sung HW
J Biomater Sci Polym Ed; 2003; 14(5):481-95. PubMed ID: 12807149
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of genipin-crosslinked rat acellular spinal cord scaffolds.
Jiang T; Ren XJ; Tang JL; Yin H; Wang KJ; Zhou CL
Mater Sci Eng C Mater Biol Appl; 2013 Aug; 33(6):3514-21. PubMed ID: 23706241
[TBL] [Abstract][Full Text] [Related]
9. Monodisperse gelatin microspheres as a drug delivery vehicle: release profile and effect of crosslinking density.
Choy YB; Cheng F; Choi H; Kim KK
Macromol Biosci; 2008 Aug; 8(8):758-65. PubMed ID: 18446808
[TBL] [Abstract][Full Text] [Related]
10. Growth factor sequestration and enzyme-mediated release from genipin-crosslinked gelatin microspheres.
Turner PA; Thiele JS; Stegemann JP
J Biomater Sci Polym Ed; 2017 Nov; 28(16):1826-1846. PubMed ID: 28696181
[TBL] [Abstract][Full Text] [Related]
11. Creation of macroporous calcium phosphate cements as bone substitutes by using genipin-crosslinked gelatin microspheres.
Li M; Liu X; Liu X; Ge B; Chen K
J Mater Sci Mater Med; 2009 Apr; 20(4):925-34. PubMed ID: 19052846
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis and properties evaluation of gelatin microspheres crosslinked with glutaraldehyde and 3-glycidoxypropyltrimethoxysilane as drug delivery systems for the antibiotic vancomycin.
Nouri-Felekori M; Khakbiz M; Nezafati N; Mohammadi J; Eslaminejad MB
Int J Pharm; 2019 Feb; 557():208-220. PubMed ID: 30597262
[TBL] [Abstract][Full Text] [Related]
13. The development of genipin-crosslinked poly(caprolactone) (PCL)/gelatin nanofibers for tissue engineering applications.
Kim MS; Jun I; Shin YM; Jang W; Kim SI; Shin H
Macromol Biosci; 2010 Jan; 10(1):91-100. PubMed ID: 19685497
[TBL] [Abstract][Full Text] [Related]
14. Gelatin microspheres encapsulated with a nonpeptide angiogenic agent, ginsenoside Rg1, for intramyocardial injection in a rat model with infarcted myocardium.
Wei HJ; Yang HH; Chen CH; Lin WW; Chen SC; Lai PH; Chang Y; Sung HW
J Control Release; 2007 Jul; 120(1-2):27-34. PubMed ID: 17532519
[TBL] [Abstract][Full Text] [Related]
15. [The influences of cross-linking agent on the composite bio-sponge].
Li D; Li P; Luo J; Huang L
Zhongguo Yi Liao Qi Xie Za Zhi; 2012 Sep; 36(5):317-20. PubMed ID: 23289331
[TBL] [Abstract][Full Text] [Related]
16. [Preparation and biological characteristics of a new doxorubicin-gelatin-microspheres for hepatic artery embolization].
Wan Y; Ma Y; Chen XL; Duan LG; Luo DH; Xia CQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):119-24. PubMed ID: 21355316
[TBL] [Abstract][Full Text] [Related]
17. Formation of model hepatocellular aggregates in a hydrogel scaffold using degradable genipin crosslinked gelatin microspheres as cell carriers.
Lau TT; Lee LQ; Leong W; Wang DA
Biomed Mater; 2012 Dec; 7(6):065003. PubMed ID: 23117748
[TBL] [Abstract][Full Text] [Related]
18. Some physical and microstructural properties of genipin-crosslinked gelatin-maltodextrin hydrogels.
Nickerson MT; Farnworth R; Wagar E; Hodge SM; Rousseau D; Paulson AT
Int J Biol Macromol; 2006 Feb; 38(1):40-4. PubMed ID: 16443267
[TBL] [Abstract][Full Text] [Related]
19. Microencapsulation of isoniazid in genipin-crosslinked gelatin-A-κ-carrageenan polyelectrolyte complex.
Devi N; Maji TK
Drug Dev Ind Pharm; 2010 Jan; 36(1):56-63. PubMed ID: 19681667
[TBL] [Abstract][Full Text] [Related]
20. Effect of process variables on particle size and viability of Bifidobacterium lactis Bb-12 in genipin-gelatin microspheres.
Annan NT; Borza A; Moreau DL; Allan-Wojtas PM; Hansen LT
J Microencapsul; 2007 Mar; 24(2):152-62. PubMed ID: 17454426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
